Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for dexmethylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for dexmethylphenidate hydrochloride extended-release from Lannett, making the generic extended-rele…
-
FDA approval · 2019-11-29FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for a generic extended-release dexmethylphenidate hydrochloride product (Par Health USA, LLC) for at…
-
FDA approval · 2019-11-19FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR submitted by Sandoz Inc.
-
FDA approval · 2019-11-19FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) from Sandoz Inc, updating the product's labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-19FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2019-10-22FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approves a supplemental NDA for the methylphenidate transdermal system (patch) from Padagis US LLC, expanding the product’s approved…
-
FDA approval · 2019-10-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' methylphenidate hydrochloride as a generic ADHD medication under an ANDA (Original Application).
-
FDA approval · 2019-09-13FDA Approved: MYDAYIS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for MYDAYIS submitted by Takeda, resulting in updated labeling for the ADHD medication. The supp…
-
FDA approval · 2019-09-03FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved methylphenidate hydrochloride from XLCare Pharmaceuticals, Inc. via an Original Application (ANDA) for generic methylphenidate …
-
FDA approval · 2019-08-05FDA Approved: AMPHETAMINE SULFATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s amphetamine sulfate as an Original Application under the ANDA212619, marking a generic product …
-
FDA approval · 2019-07-30FDA Approved: GUANFACINE EXTENDED-RELEASE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for guanfacine extended-release from Upsher-Smith Laboratories, authorizing its continued market…
-
FDA approval · 2019-07-30FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)
The FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries, Inc., finalizing an updated approval for the …
-
FDA approval · 2019-07-30FDA Approved: GUANFACINE EXTENDED-RELEASE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental ANDA for guanfacine extended-release (generic) to Apotex Corp., granting regulatory approval for the generic pro…
-
FDA approval · 2019-07-19FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
The FDA approved a generic dexmethylphenidate hydrochloride product from Ascend Laboratories for the treatment of attention-deficit/hyperact…
-
FDA approval · 2019-07-03FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of four amphetamine salts (dextroamphetamine saccharate, amphetamine as…
-
FDA approval · 2019-06-14FDA Approved: APTENSIO XR — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for APTENSIO XR (methylphenidate hydrochloride) from Rhodes Pharmaceuticals L.P.
-
FDA approval · 2019-05-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s methylphenidate hydrochloride granules as an original generic drug application.
-
FDA approval · 2019-05-16FDA Approved: JORNAY PM EXTENDED-RELEASE — Supplemental Application (Ironshore Pharmaceuticals Inc.)
FDA approves a supplemental application for Jornay PM Extended-Release (methylphenidate hydrochloride) from Ironshore Pharmaceuticals. The a…
-
FDA approval · 2019-04-30FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc. The approval updates the labe…
-
FDA approval · 2019-04-22FDA Approved: MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR — Original Application (SpecGx LLC)
FDA approved the original ANDA for MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR, a generic extended-release amphetamine formulation…
-
FDA approval · 2019-04-17FDA Approved: AMPHETAMINE SULFATE — Original Application (Aurolife Pharma, LLC)
FDA approved the original application for Amphetamine Sulfate from Aurolife Pharma, LLC, expanding generic options for this stimulant medica…
-
FDA approval · 2019-02-05FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) from NextWave Pharmaceuticals, expanding its approved use under th…
-
FDA approval · 2019-02-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Neolpharma, Inc.)
FDA approved Neolpharma, Inc.'s methylphenidate hydrochloride generic under an original ANDA. The product is indicated for attention-deficit…
-
FDA approval · 2019-01-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' generic combination of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate monohydrate,…